D.E. Shaw & Co’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Buy |
3,835,407
+783,035
| +26% | +$3.66M | 0.01% | 762 |
|
|
2025
Q1 | $16.8M | Buy |
3,052,372
+1,688,920
| +124% | +$9.27M | 0.01% | 747 |
|
|
2024
Q4 | $4.62M | Buy |
1,363,452
+378,437
| +38% | +$1.28M | ﹤0.01% | 1351 |
|
|
2024
Q3 | $2.81M | Buy |
985,015
+466,991
| +90% | +$1.33M | ﹤0.01% | 1611 |
|
|
2024
Q2 | $1.17M | Sell |
518,024
-188,987
| -27% | -$425K | ﹤0.01% | 2099 |
|
|
2024
Q1 | $1.56M | Sell |
707,011
-347,599
| -33% | -$768K | ﹤0.01% | 1900 |
|
|
2023
Q4 | $2.48M | Buy |
1,054,610
+179,200
| +20% | +$421K | ﹤0.01% | 1634 |
|
|
2023
Q3 | $1.63M | Buy |
875,410
+149,359
| +21% | +$278K | ﹤0.01% | 1810 |
|
|
2023
Q2 | $1.9M | Buy |
726,051
+593,872
| +449% | +$1.56M | ﹤0.01% | 1773 |
|
|
2023
Q1 | $215K | Sell |
132,179
-30,200
| -19% | -$49.2K | ﹤0.01% | 2782 |
|
|
2022
Q4 | $216K | Buy |
162,379
+5,124
| +3% | +$6.82K | ﹤0.01% | 3004 |
|
|
2022
Q3 | $245K | Buy |
157,255
+108,392
| +222% | +$169K | ﹤0.01% | 3148 |
|
|
2022
Q2 | $75K | Sell |
48,863
-100,183
| -67% | -$154K | ﹤0.01% | 3599 |
|
|
2022
Q1 | $382K | Buy |
+149,046
| New | +$382K | ﹤0.01% | 3341 |
|
|
2021
Q3 | – | Sell |
-261,488
| Closed | -$1.06M | – | 3889 |
|
|
2021
Q2 | $1.06M | Sell |
261,488
-723,828
| -73% | -$2.95M | ﹤0.01% | 2458 |
|
|
2021
Q1 | $4.44M | Buy |
985,316
+91,718
| +10% | +$414K | ﹤0.01% | 1413 |
|
|
2020
Q4 | $4.4M | Buy |
893,598
+57,301
| +7% | +$282K | ﹤0.01% | 1373 |
|
|
2020
Q3 | $4.96M | Buy |
836,297
+335,117
| +67% | +$1.99M | 0.01% | 1196 |
|
|
2020
Q2 | $1.33M | Buy |
501,180
+19,163
| +4% | +$51K | ﹤0.01% | 1793 |
|
|
2020
Q1 | $940K | Buy |
+482,017
| New | +$940K | ﹤0.01% | 1876 |
|